Shorting should be liked, not loathed, page-4

Bonehead,

Sorry, but I'm afraid you misunderstand.

The relevant data I quoted relates to the RMD shares whihc are traded in the US, i.e., Resmed Inc., which is where the stock is ultimately priced (the Australian listing is merely a 10:1 Chess Depository Instrument [CDI]), and the US is where most of the shorting activity has occurred (Australian institutions are generally long the stock; its the US hedge funds who have been shorting and subsequently convering)

My source is Bloomberg and the ticker for the US listing of Resmed is "RMD US Equity"

'Trust this clears up any confusion.